Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Verification of the Efficacy / Safety of the Intratympanic Drug Delivery Vehicle for Treating Intractable Hearing Loss (pilot Study)

NCT04766853 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT04766853
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04766853 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Verification of the Efficacy / Safety of the Intratympanic Drug Delivery Vehicle for Treating Intractable Hearing Loss (pilot Study)
Lead sponsor
Seoul National University Hospital
Phase
Phase 1/2
Overall status
Completed
Start date
July 22, 2021
Completion date
July 19, 2024
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hearing loss, noise-induced, hearing loss, ototoxic, hearing loss, sudden, meniere disease